Gastrointestinal stromal tumors, version 2.2014.
Journal: Journal Of The National Comprehensive Cancer Network : JNCCN
Published:
Abstract
Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights highlight the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while on imatinib and/or sunitinib.
Authors
Margaret Von Mehren, R Randall, Robert Benjamin, Sarah Boles, Marilyn Bui, Ephraim Casper, Ernest Conrad, Thomas Delaney, Kristen Ganjoo, Suzanne George, Ricardo Gonzalez, Martin Heslin, John Kane, Joel Mayerson, Sean Mcgarry, Christian Meyer, Richard O'donnell, Alberto Pappo, I Paz, John Pfeifer, Richard Riedel, Scott Schuetze, Karen Schupak, Herbert Schwartz, Brian Van Tine, Jeffrey Wayne, Mary Bergman, Hema Sundar
Relevant Conditions